Ayyoub M - Search Results

1

Distinct but overlapping T helper epitopes in the 37-58 region of SSX-2.

Ayyoub M, Merlo A, Hesdorffer CS, Speiser D, Rimoldi D, Cerottini JC, Ritter G, Chen YT, Old LJ, Stevanovic S, Valmori D. Ayyoub M, et al. Clin Immunol. 2005 Jan;114(1):70-8. doi: 10.1016/j.clim.2004.08.014. Clin Immunol. 2005. PMID: 15596411

2

Proteasome-assisted identification of a SSX-2-derived epitope recognized by tumor-reactive CTL infiltrating metastatic melanoma.

Ayyoub M, Stevanovic S, Sahin U, Guillaume P, Servis C, Rimoldi D, Valmori D, Romero P, Cerottini JC, Rammensee HG, Pfreundschuh M, Speiser D, Lévy F. Ayyoub M, et al. J Immunol. 2002 Feb 15;168(4):1717-22. doi: 10.4049/jimmunol.168.4.1717. J Immunol. 2002. PMID: 11823502

3

Tumor-reactive, SSX-2-specific CD8+ T cells are selectively expanded during immune responses to antigen-expressing tumors in melanoma patients.

Ayyoub M, Rimoldi D, Guillaume P, Romero P, Cerottini JC, Valmori D, Speiser D. Ayyoub M, et al. Cancer Res. 2003 Sep 1;63(17):5601-6. Cancer Res. 2003. PMID: 14500401

4

SSX antigens as tumor vaccine targets in human sarcoma.

Ayyoub M, Brehm M, Metthez G, Talbot S, Dutoit V, Taub RN, Keohan ML, Gure AO, Chen YT, Williamson B, Jungbluth AA, Old LJ, Hesdorffer CS, Valmori D. Ayyoub M, et al. Cancer Immun. 2003 Oct 9;3:13. Cancer Immun. 2003. PMID: 14533943

5

Simultaneous CD8+ T cell responses to multiple tumor antigen epitopes in a multipeptide melanoma vaccine.

Valmori D, Dutoit V, Ayyoub M, Rimoldi D, Guillaume P, Liénard D, Lejeune F, Cerottini JC, Romero P, Speiser DE. Valmori D, et al. Among authors: ayyoub m. Cancer Immun. 2003 Oct 28;3:15. Cancer Immun. 2003. PMID: 14580186

6

An immunodominant SSX-2-derived epitope recognized by CD4+ T cells in association with HLA-DR.

Ayyoub M, Hesdorffer CS, Montes M, Merlo A, Speiser D, Rimoldi D, Cerottini JC, Ritter G, Scanlan M, Old LJ, Valmori D. Ayyoub M, et al. J Clin Invest. 2004 Apr;113(8):1225-33. doi: 10.1172/JCI20667. J Clin Invest. 2004. PMID: 15085202 Free PMC article.

7

Identification of an SSX-2 epitope presented by dendritic cells to circulating autologous CD4+ T cells.

Ayyoub M, Hesdorffer CS, Metthez G, Stevanovic S, Ritter G, Chen YT, Old LJ, Speiser D, Cerottini JC, Valmori D. Ayyoub M, et al. J Immunol. 2004 Jun 1;172(11):7206-11. doi: 10.4049/jimmunol.172.11.7206. J Immunol. 2004. PMID: 15153546

8

CD4+ T cell responses to SSX-4 in melanoma patients.

Ayyoub M, Merlo A, Hesdorffer CS, Rimoldi D, Speiser D, Cerottini JC, Chen YT, Old LJ, Stevanovic S, Valmori D. Ayyoub M, et al. J Immunol. 2005 Apr 15;174(8):5092-9. doi: 10.4049/jimmunol.174.8.5092. J Immunol. 2005. PMID: 15814740

9

Identification of B cell epitopes recognized by antibodies specific for the tumor antigen NY-ESO-1 in cancer patients with spontaneous immune responses.

Valmori D, Souleimanian NE, Hesdorffer CS, Ritter G, Old LJ, Ayyoub M. Valmori D, et al. Among authors: ayyoub m. Clin Immunol. 2005 Oct;117(1):24-30. doi: 10.1016/j.clim.2005.05.003. Clin Immunol. 2005. PMID: 15994128

10

Quantitative and qualitative assessment of circulating NY-ESO-1 specific CD4+ T cells in cancer-free individuals.

Valmori D, Souleimanian NE, Hesdorffer CS, Old LJ, Ayyoub M. Valmori D, et al. Among authors: ayyoub m. Clin Immunol. 2005 Nov;117(2):161-7. doi: 10.1016/j.clim.2005.07.004. Epub 2005 Aug 15. Clin Immunol. 2005. PMID: 16103015

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

102 results

Search Page

Filters